The DOI matches its Crossref record; 126 of the 126 references it cites were found in a registry or an index.
Drug development of MET inhibitors: targeting oncogene addiction and expedience
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
MET Amplification Leads to Gefitinib Resistance in Lung Cancer by Activating ERBB3 Signaling
Engelman, J. A., Zejnullahu, K., Mitsudomi, T., Song, Y., Hyland, C., Park, J. O., Lindeman, N., Gale, C.-M., Zhao, X., Christensen, J., et al. (2007) · Science · doi:10.1126/science.1141478 · Cited by 4,496
Epidermal growth factor receptor mutations in lung cancer
Sharma, S. V., Bell, D. W., Settleman, J., & Haber, D. A. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2088 · Cited by 3,170
Michalopoulos, G. K., & DeFrances, M. C. (1997) · Science · doi:10.1126/science.276.5309.60 · Cited by 2,828
Met, metastasis, motility and more
Birchmeier, C., Birchmeier, W., Gherardi, E., & Vande Woude, G. F. (2003) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1261 · Cited by 2,602
Global Survey of Phosphotyrosine Signaling Identifies Oncogenic Kinases in Lung Cancer
Rikova, K., Guo, A., Zeng, Q., Possemato, A., Yu, J., Haack, H., Nardone, J., Lee, K., Reeves, C., Li, Y., et al. (2007) · Cell · doi:10.1016/j.cell.2007.11.025 · Cited by 2,317
Stromal fibroblasts in cancer initiation and progression
Bhowmick, N. A., Neilson, E. G., & Moses, H. L. (2004) · Nature · doi:10.1038/nature03096 · Cited by 2,302
Bean, J., Brennan, C., Shih, J.-Y., Riely, G., Viale, A., Wang, L., Chitale, D., Motoi, N., Szoke, J., Broderick, S., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0710370104 · Cited by 1,598
Schmidt, L., Duh, F.-M., Chen, F., Kishida, T., Glenn, G., Choyke, P., Scherer, S. W., Zhuang, Z., Lubensky, I., Dean, M., et al. (1997) · Nature Genetics · doi:10.1038/ng0597-68 · Cited by 1,524
Scatter factor/hepatocyte growth factor is essential for liver development
Schmidt, C., Bladt, F., Goedecke, S., Brinkmann, V., Zschiesche, W., Sharpe, M., Gherardi, E., & Birchmeler, C. (1995) · Nature · doi:10.1038/373699a0 · Cited by 1,394
Bussolino, F., Di Renzo, M. F., Ziche, M., Bocchietto, E., Olivero, M., Naldini, L., Gaudino, G., Tamagnone, L., Coffer, A., & Comoglio, P. M. (1992) · The Journal of cell biology · doi:10.1083/jcb.119.3.629 · Cited by 1,337
Self-citationHypoxia promotes invasive growth by transcriptional activation of the met protooncogene
Pennacchietti, S., Michieli, P., Galluzzo, M., Mazzone, M., Giordano, S., & Comoglio, P. M. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00085-0 · Cited by 1,311
Self-citationEssential role for the c-met receptor in the migration of myogenic precursor cells into the limb bud
Bladt, F., Riethmacher, D., Isenmann, S., Aguzzi, A., & Birchmeier, C. (1995) · Nature · doi:10.1038/376768a0 · Cited by 1,284
Green, D. R., & Evan, G. I. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00024-7 · Cited by 1,254
Molecular cloning of a new transforming gene from a chemically transformed human cell line
Cooper, C. S., Park, M., Blair, D. G., Tainsky, M. A., Huebner, K., Croce, C. M., & Vande Woude, G. F. (1984) · Nature · doi:10.1038/311029a0 · Cited by 989
Coactivation of receptor tyrosine kinases affects the response of tumor cells to targeted therapies
Stommel, J. M., Kimmelman, A. C., Ying, H., Nabioullin, R., Ponugoti, A. H., Wiedemeyer, R., Stegh, A. H., Bradner, J. E., Ligon, K. L., Brennan, C., et al. (2007) · Science · doi:10.1126/science.1142946 · Cited by 938
Zou, H. Y., Li, Q., Lee, J. H., Arango, M. E., McDonnell, S. R., Yamazaki, S., Koudriakova, T. B., Alton, G., Cui, J. J., Kung, P.-P., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4443 · Cited by 745
Scatter-factor and semaphorin receptors: cell signalling for invasive growth
Trusolino, L., & Comoglio, P. M. (2002) · Nature Reviews Cancer · doi:10.1038/nrc779 · Cited by 745
Self-citationHepatocyte growth factor gene therapy of liver cirrhosis in rats
Ueki, T., Kaneda, Y., Tsutsui, H., Nakanishi, K., Sawa, Y., Morishita, R., Matsumoto, K., Nakamura, T., Takahashi, H., Okamoto, E., et al. (1999) · Nature Medicine · doi:10.1038/5593 · Cited by 587
Naldini, L., Tamagnone, L., Vigna, E., Sachs, M., Hartmann, G., Birchmeier, W., Daikuhara, Y., Tsubouchi, H., Blasi, F., & Comoglio, P. M. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05588.x · Cited by 565
Self-citationInvasive growth: a MET-driven genetic programme for cancer and stem cells
Boccaccio, C., & Comoglio, P. M. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1912 · Cited by 538
Self-citationInduction of epithelial tubules by growth factor HGF depends on the STAT pathway
Boccaccio, C., Andò, M., Tamagnone, L., Bardelli, A., Michieli, P., Battistini, C., & Comoglio, P. M. (1998) · Nature · doi:10.1038/34657 · Cited by 519
Self-citationCD44 is required for two consecutive steps in HGF/c-Met signaling
Orian-Rousseau, V., Chen, L., Sleeman, J. P., Herrlich, P., & Ponta, H. (2002) · Genes & Development · doi:10.1101/gad.242602 · Cited by 518
Signaling networks assembled by oncogenic EGFR and c-Met
Guo, A., Villén, J., Kornhauser, J., Lee, K. A., Stokes, M. P., Rikova, K., Possemato, A., Nardone, J., Innocenti, G., Wetzel, R., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0707270105 · Cited by 505
Christensen, J. G., Schreck, R., Burrows, J., Kuruganti, P. A., Chan, E., Le, P., Chen, J., Wang, X., Ruslim, L., Blake, R. A., et al. (2003) · PubMed · Cited by 497
Smolen, G. A., Sordella, R., Muir, B., Mohapatra, G., Barmettler, A., Archibald, H., Kim, W. J., Okimoto, R. A., Bell, D. W., Sgroi, D. C., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0508776103 · Cited by 485
Renzo, M. F. D., Olivero, M., Giacomini, A., Porte, H., Chastre, E., Mirossay, L., Nordlinger, B., Bretti, S., Bottardi, S., & Giordano, S. (1995) · PubMed · Cited by 471
Self-citationThe Semaphorin 4D receptor controls invasive growth by coupling with Met
Giordano, S., Corso, S., Conrotto, P., Artigiani, S., Gilestro, G., Barberis, D., Tamagnone, L., & Comoglio, P. M. (2002) · Nature Cell Biology · doi:10.1038/ncb843 · Cited by 444
Self-citationOncogene addiction: setting the stage for molecularly targeted cancer therapy
Sharma, S. V., & Settleman, J. (2007) · Genes & Development · doi:10.1101/gad.1609907 · Cited by 441
Takayama, H., LaRochelle, W. J., Sharp, R., Otsuka, T., Kriebel, P., Anver, M., Aaronson, S. A., & Merlino, G. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.2.701 · Cited by 440
Myocardial protection from ischemia/reperfusion injury by endogenous and exogenous HGF
Nakamura, T., Mizuno, S., Matsumoto, K., Sawa, Y., Matsuda, H., & Nakamura, T. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10226 · Cited by 434
A Signaling Adapter Function for α6β4 Integrin in the Control of HGF-Dependent Invasive Growth
Trusolino, L., Bertotti, A., & Comoglio, P. M. (2001) · Cell · doi:10.1016/s0092-8674(01)00567-0 · Cited by 420
Self-citationXiao, G.-H. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.011532898 · Cited by 417
Kaposi-Novak, P. (2006) · Journal of Clinical Investigation · doi:10.1172/jci27236 · Cited by 398
Activation of hepatocyte growth factor by the plasminogen activators uPA and tPA.
Mars, W. M., Zarnegar, R., & Michalopoulos, G. K. (1993) · PubMed · Cited by 373
Rong, S., Segal, S., Anver, M., Resau, J. H., & Vande Woude, G. F. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.11.4731 · Cited by 363
Hepatocyte growth factor: Renotropic role and potential therapeutics for renal diseases
Matsumoto, K., & Nakamura, T. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.00717.x · Cited by 353
Hepatocyte growth factor and its receptor (c-MET) in prostatic carcinoma.
Humphrey, P. A., Zhu, X., Zarnegar, R., Swanson, P. E., Ratliff, T. L., Vollmer, R. T., & Day, M. L. (1995) · Europe PMC (PubMed Central) · Cited by 335
Somatic mutations of the MET oncogene are selected during metastatic spread of human HNSC carcinomas
Di Renzo, M. F., Olivero, M., Martone, T., Maffe, A., Maggiora, P., De Stefani, A., Valente, G., Giordano, S., Cortesina, G., & Comoglio, P. M. (2000) · Oncogene · doi:10.1038/sj.onc.1203455 · Cited by 332
Self-citationA novel germ line juxtamembrane Met mutation in human gastric cancer
Lee, J.-H., Han, S.-U., Cho, H., Jennings, B., Gerrard, B., Dean, M., Schmidt, L., Zbar, B., & Vande Woude, G. F. (2000) · Oncogene · doi:10.1038/sj.onc.1203874 · Cited by 329
Frequent amplification of the c-met gene in scirrhous type stomach cancer
Kuniyasu, H., Yasui, W., Kitadai, Y., Yokozaki, H., Ito, H., & Tahara, E. (1992) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(92)91548-5 · Cited by 328
Met and hepatocyte growth factor/scatter factor expression in human gliomas.
Koochekpour, S., Jeffers, M., Rulong, S., Taylor, G., Klineberg, E. O., Hudson, E. A., Resau, J. H., & Woude, G. F. V. (1997) · PubMed · Cited by 320
Lung Cancer Cell Lines Harboring MET Gene Amplification Are Dependent on Met for Growth and Survival
Lutterbach, B., Zeng, Q., Davis, L. J., Hatch, H., Hang, G., Kohl, N. E., Gibbs, J. B., & Pan, B.-S. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3495 · Cited by 320
Lyon, M., Deakin, J. A., Mizuno, K., Nakamura, T., & Gallagher, J. T. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)78113-7 · Cited by 318
Overexpression of the c-MET/HGF receptor gene in human thyroid carcinomas.
Renzo, M. F. D., Olivero, M., Ferro, S., Prat, M., Bongarzone, I., Pilotti, S., Belfiore, A., Costantino, A., Vigneri, R., & Pierotti, M. A. (1992) · PubMed · Cited by 312
A Novel One-Armed Anti-c-Met Antibody Inhibits Glioblastoma Growth In vivo
Martens, T., Schmidt, N.-O., Eckerich, C., Fillbrandt, R., Merchant, M., Schwall, R., Westphal, M., & Lamszus, K. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1418 · Cited by 305
Targeting the tumor and its microenvironment by a dual-function decoy Met receptor
Michieli, P., Mazzone, M., Basilico, C., Cavassa, S., Sottile, A., Naldini, L., & Comoglio, P. M. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.05.032 · Cited by 299
Self-citationLokker, N. A., Mark, M. R., Luis, E. A., Bennett, G. L., Robbins, K. A., Baker, J. B., & Godowski, P. J. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05315.x · Cited by 296
Wang, R., Ferrell, L. D., Faouzi, S., Maher, J. J., & Bishop, J. M. (2001) · The Journal of Cell Biology · doi:10.1083/jcb.153.5.1023 · Cited by 281
Ferracini, R., Renzo, M. F. D., Scotlandi, K., Baldini, N., Olivero, M., Lollini, P., Cremona, O., Campanacci, M., & Comoglio, P. M. (1995) · PubMed · Cited by 280
Self-citationOtsuka, T., Takayama, H., Sharp, R., Celli, G. B., LaRochelle, W. J., Bottaro, D. P., Ellmore, N., Vieira, W., Owens, J. W., Anver, M. R., et al. (1998) · PubMed · doi:10.5281/zenodo.894795 · Cited by 268
Dysregulation of Met receptor tyrosine kinase activity in invasive tumors
Danilkovitch‐Miagkova, A., & Zbar, B. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15418 · Cited by 268
Harrington, E. A., Fanidi, A., & Evan, G. I. (1994) · Current Opinion in Genetics & Development · doi:10.1016/0959-437x(94)90100-7 · Cited by 265
Expression of the Met/hepatocyte growth factor receptor in human pancreatic cancer.
Renzo, M. F. D., Poulsom, R., Olivero, M., et al. (1995) · PubMed · Cited by 262
Sema4D induces angiogenesis through Met recruitment by Plexin B1
Conrotto, P., Valdembri, D., Corso, S., Serini, G., Tamagnone, L., Comoglio, P. M., Bussolino, F., & Giordano, S. (2005) · Blood · doi:10.1182/blood-2004-07-2885 · Cited by 262
Self-citationBurgess, T., Coxon, A., Meyer, S., Sun, J., Rex, K., Tsuruda, T., Chen, Q., Ho, S.-Y., Li, L., Kaufman, S., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3329 · Cited by 252
Park, W. S., Dong, S. M., Kim, S. Y., Na, E. Y., Shin, M. S., Pi, J. H., Kim, B. J., Bae, J. H., Hong, Y. K., Lee, K. S., et al. (1999) · PubMed · Cited by 251
The MET oncogene drives a genetic programme linking cancer to haemostasis
Boccaccio, C., Sabatino, G., Medico, E., Girolami, F., Follenzi, A., Reato, G., Sottile, A., Naldini, L., & Comoglio, P. M. (2005) · Nature · doi:10.1038/nature03357 · Cited by 250
Self-citationCoexpression of hepatocyte growth factor and receptor (Met) in human breast carcinoma.
Tuck, A. B., Park, M., Sterns, E. E., Boag, A., & Elliott, B. E. (1996) · Europe PMC (PubMed Central) · Cited by 244
Dysregulation of Met receptor tyrosine kinase activity in invasive tumors
Danilkovitch-Miagkova, A., & Zbar, B. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215418 · Cited by 244
Crystal structure of the HGF β‐chain in complex with the Sema domain of the Met receptor
Stamos, J., Lazarus, R. A., Yao, X., Kirchhofer, D., & Wiesmann, C. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600243 · Cited by 240
BindingDB (2025) · PubMed · doi:10.7270/q2dv1qm3 · Cited by 235
Kuba, K., Matsumoto, K., Date, K., Shimura, H., Tanaka, M., & Nakamura, T. (2000) · PubMed · Cited by 227
Identification of a Competitive HGF Antagonist Encoded by an Alternative Transcript
Chan, A. M.-L., Rubin, J. S., Bottaro, D. P., Hirschfield, D. W., Chedid, M., & Aaronson, S. A. (1991) · Science · doi:10.1126/science.1720571 · Cited by 218
Overexpression of theMET/HGF receptor in ovarian cancer
Di Renzo, M. F., Olivero, M., Katsaros, D., Crepaldi, T., Gaglia, P., Zola, P., Sismondi, P., & Comoglio, P. M. (1994) · International Journal of Cancer · doi:10.1002/ijc.2910580507 · Cited by 212
Self-citationThe Sema domain of Met is necessary for receptor dimerization and activation
Kong-Beltran, M., Stamos, J., & Wickramasinghe, D. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.06.013 · Cited by 209
Series Introduction: Invasive growth: from development to metastasis
Comoglio, P. M., & Trusolino, L. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15392 · Cited by 200
Self-citationThe Hepatocyte Growth Factor Regulatory Factors in Human Breast Cancer
Parr, C., Watkins, G., Mansel, R. E., & Jiang, W. G. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-0553-3 · Cited by 198
Takayama, H., La Rochelle, W. J., Anver, M., Bockman, D. E., & Merlino, G. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.12.5866 · Cited by 195
Orian-Rousseau, V., Morrison, H., Matzke, A., Kastilan, T., Pace, G., Herrlich, P., & Ponta, H. (2007) · Molecular Biology of the Cell · doi:10.1091/mbc.e06-08-0674 · Cited by 190
Soman, N. R., Correa, P., Ruiz, B. A., & Wogan, G. N. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.11.4892 · Cited by 190
Aguirre Ghiso, J. A., Alonso, D. F., Farías, E. F., Gomez, D. E., & Bal de Kier Joffè, E. (1999) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.1999.00507.x · Cited by 185
Interplay between scatter factor receptors and B plexins controls invasive growth
Conrotto, P., Corso, S., Gamberini, S., Comoglio, P. M., & Giordano, S. (2004) · Oncogene · doi:10.1038/sj.onc.1207650 · Cited by 183
Self-citationHara, T., Ooi, A., Kobayashi, M., Mai, M., Yanagihara, K., & Nakanishi, I. (1998) · PubMed · Cited by 183
Berthou, S., Aebersold, D. M., Schmidt, L. S., Stroka, D., Heigl, C., Streit, B., Stalder, D., Gruber, G., Liang, C., Howlett, A. R., et al. (2004) · Oncogene · doi:10.1038/sj.onc.1207691 · Cited by 178
Series Introduction: Invasive growth: from development to metastasis
Comoglio, P. M., & Trusolino, L. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215392 · Cited by 174
Self-citationBellusci, S., Moens, G., Gaudino, G., Comoglio, P. M., Nakamura, T., Thiery, J. P., & Jouanneau, J. (1994) · PubMed · Cited by 168
Self-citationOut of air is not out of action
Bottaro, D. P., & Liotta, L. A. (2003) · Nature · doi:10.1038/423593a · Cited by 168
NK4 (HGF‐antagonist/angiogenesis inhibitor) in cancer biology and therapeutics
Matsumoto, K., & Nakamura, T. (2003) · Cancer Science · doi:10.1111/j.1349-7006.2003.tb01440.x · Cited by 166
Petrelli, A., Circosta, P., Granziero, L., Mazzone, M., Pisacane, A., Fenoglio, S., Comoglio, P. M., & Giordano, S. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0508156103 · Cited by 164
Self-citationAmit, I., Wides, R., & Yarden, Y. (2007) · Molecular Systems Biology · doi:10.1038/msb4100195 · Cited by 163
Miller, C. T., Lin, L., Casper, A. M., Lim, J., Thomas, D. G., Orringer, M. B., Chang, A. C., Chambers, A. F., Giordano, T. J., Glover, T. W., et al. (2006) · Oncogene · doi:10.1038/sj.onc.1209057 · Cited by 161
Boccaccio, C., Gaudino, G., Gambarotta, G., Galimi, F., & Comoglio, P. M. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)99953-9 · Cited by 160
Self-citationSynergism between INK4a/ARF inactivation and aberrant HGF/SF signaling in rhabdomyosarcomagenesis
Sharp, R., Recio, J. A., Jhappan, C., Otsuka, T., Liu, S., Yu, Y., Liu, W., Anver, M., Navid, F., Helman, L. J., et al. (2002) · Nature Medicine · doi:10.1038/nm787 · Cited by 158
Camp, R. L., Rimm, E. B., & Rimm, D. L. (1999) · Cancer · doi:10.1002/(sici)1097-0142(19991201)86:11<2259::aid-cncr13>3.0.co;2-2 · Cited by 157
Gene amplification in gastric and esophageal adenocarcinomas.
Houldsworth, J., Cordon‐Cardo, C., Ladanyi, M., Kelsen, D. P., & Chaganti, R. S. K. (1990) · PubMed · Cited by 156
Ivan, M., BOND, J. A., Prat, M., et al. (1997) · Oncogene · doi:10.1038/sj.onc.1201083 · Cited by 152
Kim, K. J., Wang, L., Su, Y.-C., Gillespie, G. Y., Salhotra, A., Lal, B., & Laterra, J. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1793 · Cited by 150
K252a inhibits the oncogenic properties of Met, the HGF receptor
Morotti, A., Mila, S., Accornero, P., Tagliabue, E., & Ponzetto, C. (2002) · Oncogene · doi:10.1038/sj.onc.1205622 · Cited by 149
Jun, H. T., Sun, J., Rex, K. L., et al. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-2969 · Cited by 146
Zeng, Q., Chen, S., You, Z., Yang, F., Carey, T. E., Saims, D., & Wang, C. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m201598200 · Cited by 143
Mutant Met-mediated transformation is ligand-dependent and can be inhibited by HGF antagonists
Michieli, P., Basilico, C., Pennacchietti, S., Maffé, A., Tamagnone, L., Giordano, S., Bardelli, A., & Comoglio, P. M. (1999) · Oncogene · doi:10.1038/sj.onc.1202899 · Cited by 140
Self-citationShima, N., Nagao, M., Ogaki, F., Tsuda, E., Murakami, A., & Higashio, K. (1991) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(05)81187-8 · Cited by 139
Bertotti, A., Comoglio, P. M., & Trusolino, L. (2006) · The Journal of Cell Biology · doi:10.1083/jcb.200605114 · Cited by 132
Self-citationAndermarcher, E., Surani, M. A., & Gherardi, E. (1996) · Developmental Genetics · Cited by 130
Ferracini, R., Olivero, M., Renzo, M. F. D., Martano, M., Giovanni, C. D., Nanni, P., Basso, G., Scotlandi, K., Lollini, P., & Comoglio, P. M. (1996) · PubMed · Cited by 122
Self-citationTong, C. Y., Hui, A. B., Yin, X.-L., Pang, J. C., Zhu, X.-L., Poon, W. S., & Ng, H. (2004) · Journal of Neurosurgery Pediatrics · doi:10.3171/ped.2004.100.2.0187 · Cited by 116
Transgenic expression of tpr-met oncogene leads to development of mammary hyperplasia and tumors.
Liang, T. J., Reid, A. E., Xavier, R. J., Cardiff, R. D., & Wang, T. C. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118744 · Cited by 115
Lietha, D., Chirgadze, D. Y., Mulloy, B., Blundell, T. L., & Gherardi, E. (2001) · The EMBO Journal · doi:10.1093/emboj/20.20.5543 · Cited by 114
Tavian, D., Petro, G. D., Benetti, A., Portolani, N., Giulini, S. M., & Barlati, S. (2000) · International Journal of Cancer · Cited by 110
Graveel, C., Su, Y., Koeman, J. M., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407651101 · Cited by 108
A role for HGF/SF in neural induction and its expression in Hensen’s node during gastrulation
Streit, A., Stern, C. D., Théry, C., Ireland, G. W., Aparicio, S. A. J. R., Sharpe, M. J., & Gherardi, E. (1995) · Development · doi:10.1242/dev.121.3.813 · Cited by 107
Tyrosine kinase signal specificity: lessons from the HGF receptor
Bertotti, A., & Comoglio, P. M. (2003) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2003.09.001 · Cited by 105
Self-citationCho, N. L., Javid, S. H., Carothers, A. M., Redston, M. S., & Bertagnolli, M. M. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3026 · Cited by 104
Atabey, N., Gao, Y., Yao, Z., Breckenridge, D., Soon, L., Soriano, J. V., Burke, T. R., & Bottaro, D. P. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m010202200 · Cited by 100
An uncleavable form of pro–scatter factor suppresses tumor growth and dissemination in mice
Mazzone, M., Basilico, C., Cavassa, S., Pennacchietti, S., Risio, M., Naldini, L., Comoglio, P. M., & Michieli, P. (2004) · Journal of Clinical Investigation · doi:10.1172/jci22235 · Cited by 97
Self-citationExpression of c-Met and Heparan-Sulfate Proteoglycan Forms of CD44 in Colorectal Cancer
Wielenga, V. T., van der Voort, R., Taher, T. E. I., Smit, L., Beuling, E. A., van Krimpen, C., Spaargaren, M., & Pals, S. T. (2000) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64793-1 · Cited by 92
Matsumoto, K., Kataoka, H., Date, K., & Nakamura, T. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.36.22913 · Cited by 91
Kirchhofer, D., Yao, X., Peek, M., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m404795200 · Cited by 89
Interactions between scatter factors and their receptors: hints for therapeutic applications
Trusolino, L., Pugliese, L., & Comoglio, P. M. (1998) · The FASEB Journal · doi:10.1096/fasebj.12.13.1267 · Cited by 85
Self-citationEXPRESSION OFMet PROTEIN IN THYROID TUMOURS
Ruco, L. P., Ranalli, T., Marzullo, A., Bianco, P., Prat, M., Comoglio, P. M., & Baroni, C. D. (1996) · The Journal of Pathology · doi:10.1002/(sici)1096-9896(199611)180:3<266::aid-path658>3.0.co;2-q · Cited by 83
Self-citationHepatocyte Growth Factor Gene Transfer to Alveolar Septa for Effective Suppression of Lung Fibrosis
Watanabe, M., Ebina, M., Orson, F. M., Nakamura, A., Kubota, K., Koinuma, D., Akiyama, K.-I., Maemondo, M., Ohkouchi, S., Tahara, M., et al. (2005) · Molecular Therapy · doi:10.1016/j.ymthe.2005.02.019 · Cited by 80
Angiogenesis inhibitors: motivators of metastasis?
Steeg, P. S. (2003) · Nature Medicine · doi:10.1038/nm0703-822 · Cited by 77
A Five-Amino-Acid Peptide Blocks Met- and Ron-Dependent Cell Migration
Matzke, A., Herrlich, P. A., Ponta, H., & Orian‐Rousseau, V. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0207 · Cited by 73
Cellular and Molecular Pathways that Lead to Progression and Regression of Renal Fibrogenesis
Okada, H., & Kalluri, R. K. (2005) · Current Molecular Medicine · doi:10.2174/1566524054553478 · Cited by 70
Montesano, R., Soriano, J. V., Malinda, K. M., Ponce, M. L., Bafico, A., Kleinman, H. K., Bottaro, D. P., & Aaronson, S. A. (1998) · PubMed · doi:10.5281/zenodo.894803 · Cited by 63
Hepatocyte growth factor specifically binds to sulfoglycolipids
Kobayashi, T., Honke, K., Miyazaki, T., Matsumoto, K., Nakamura, T., Ishizuka, I., & Makita, A. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)36956-9 · Cited by 57
MET receptor is overexpressed but not mutated in oral squamous cell carcinomas
Morello, S., Olivero, M., Aimetti, M., Bernardi, M., Berrone, S., Renzo, M. F. D., & Giordano, S. (2001) · Journal of Cellular Physiology · doi:10.1002/jcp.10010 · Cited by 56
Self-citationHepatocyte Growth Factor Receptor in Acute Tubular Necrosis
Rabkin, R., Fervenza, F. C., Tsao, T., Sibley, R. K., Friedlaender, M. M., Hsu, F. W., Lassman, C., Hausmann, M., Huie, P., & SCHWALL, R. H. (2001) · Journal of the American Society of Nephrology · doi:10.1681/asn.v123531 · Cited by 55
Regulation of c-Met-dependent gene expression by PTEN
Abounader, R., Reznik, T. E., Colantuoni, C., Martínez-Murillo, F., Rosen, E. M., & Laterra, J. (2004) · Oncogene · doi:10.1038/sj.onc.1208146 · Cited by 53
Garcia, Á. T., Rosen, L. S., Cunningham, C. C., Nemunaitis, J. J., Li, C., Rulewski, N., Dovholuk, A., Savage, R. E., Chan, T.-C., Bukowksi, R., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.25.18_suppl.3525 · Cited by 50
Eder, J. P., Heath, E. I., Appleman, L. J., Shapiro, G. I., Wang, D., Malburg, L., Zhu, A. X., Leader, T., Wolanski, A., & LoRusso, P. M. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.25.18_suppl.3526 · Cited by 47
Hepatocyte Growth Factor Sensitizes Human Ovarian Carcinoma Cell Lines to Paclitaxel and Cisplatin
Rasola, A., Anguissola, S., Ferrero, N. M., Gramaglia, D., Maffé, A., Maggiora, P., Comoglio, P. M., & Renzo, M. F. D. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-2383 · Cited by 46
Self-citationNK4 gene therapy targeting HGF-Met and angiogenesis
Matsumoto, K. (2007) · Frontiers in bioscience · doi:10.2741/2813 · Cited by 42
Coltella, N., Rasola, A., Nano, E., Bardella, C., Fassetta, M., Filigheddu, N., Graziani, A., Comoglio, P. M., & Renzo, M. F. D. (2006) · International Journal of Cancer · doi:10.1002/ijc.21766 · Cited by 39
Self-citationMichieli, P., Cavassa, S., Basilico, C., Luca, A. D., Mazzone, M., Asti, C., Chiusaroli, R., Guglielmi, M. B., Bossù, P., Colotta, F., et al. (2002) · Nature Biotechnology · doi:10.1038/nbt0502-488 · Cited by 29
Self-citationJeay, S., Munshi, N., Hill, J. E., Moussa, M. M., Ashwell, M. A., Leggett, D., & Li, C. (2007) · Cancer Research · Cited by 18
Cited by
Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?
Trachootham, D., Alexandre, J., & Huang, P. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2803 · Cited by 5,452
Comprehensive review of targeted therapy for colorectal cancer
Xie, Y.-H., Chen, Y.-X., & Fang, J.-Y. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-0116-z · Cited by 1,687
Pathogenesis, Diagnosis, and Management of Cholangiocarcinoma
Ilyas, S. I., & Gores, G. J. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.10.013 · Cited by 1,307
MET signalling: principles and functions in development, organ regeneration and cancer
Trusolino, L., Bertotti, A., & Comoglio, P. M. (2010) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3012 · Cited by 1,240
Self-citationRational, biologically based treatment of EGFR-mutant non-small-cell lung cancer
Pao, W., & Chmielecki, J. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2947 · Cited by 1,083
Metadata
- Authors
- Comoglio, P. M., Giordano, S., & Trusolino, L.
- Venue
- Nature Reviews Drug Discovery
- Published
- 2008-06
- Volume
- 7
- Issue
- 6
- Pages
- 504-516
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W2138896702
- Cited by
- 818
- References
- 126
- FWCI
- 5.85
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.